Lishomwa Ndhlovu to Mesothelioma
This is a "connection" page, showing publications Lishomwa Ndhlovu has written about Mesothelioma.
Connection Strength
0.027
-
Hoffmann PR, Panigada M, Soprana E, Terry F, Bandar IS, Napolitano A, Rose AH, Hoffmann FW, Ndhlovu LC, Belcaid M, Moise L, De Groot AS, Carbone M, Gaudino G, Matsui T, Siccardi A, Bertino P. Preclinical development of HIvax: Human survivin highly immunogenic vaccines. Hum Vaccin Immunother. 2015; 11(7):1585-95.
Score: 0.027